Alfred Health
Our Haematology Clinical Research Unit is the largest clinical trial site of its kind in Australia. Established in 2009, it is now our largest clinical trial unit, with up to 100 clinical trials running at any one time. We specialise in the treatment of blood cancers and disorders, and have expertise in Phase I and first-in-human trials of novel therapies.
We need clinical trials to prove that a new medication, device or treatment is safe and effective for people.
Without clinical trials, new treatments and medicines cannot be approved for use in Australia.
Our haematology clinical trials started in the early 1990s with a leukaemia trial. The Haematology Clinical Research Unit (CRU) was established in 2009 and is now our largest clinical trial unit, with up to 100 clinical trials running at any one time.
We specialise in the treatment of blood cancers and disorders. We have particular expertise in Phase I and first-in-human trials of novel therapies.
Find out more about our statewide clinical haematology services.
There are four different phases of a clinical trial. Each phase is represented by a roman numeral.
We provide Phase I, II, III and IV clinical trials across these blood cancers:
We also conduct clinical trials in treatments for haematological disorders such as:
The Alfred Haematology Clinical Trials team are leaders in their fields, with decades of Australian and international experience:
ClinTrial Refer is a quick way to see all of our open trials, in one place. It’s the easy way to find a trial that may be right for you or your patient.
Researchers are a step closer to offering older patients with an aggressive blood cancer, acute myeloid leukaemia (AML), a new less-toxic treatment option.
A complex surgery to remove chronic blood clots from arteries in the lungs is giving Australians and New Zealanders a second chance.
_580_400_c1.jpg "Taz shifts back into top gear")
Looking at Taran 'Taz' Child now, you won’t see signs of the turmoil that entered his life at just nine years of age.